MDGL SCHEDULE 13D/A: Activist campaign

Baker Brothers Life Sciences, L.P. and affiliated funds

Filed with the SEC on · accession 0001104659-26-124003

MDGL filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 6, 2026. Baker Brothers Life Sciences, L.P. and affiliated funds filed an amended Schedule 13D disclosing their holdings in Madrigal Pharmaceuticals, including common stock, convertible preferred stock, and prefunded warrants.

Summary of the filing

Baker Brothers Life Sciences, L.P. and affiliated funds filed an amended Schedule 13D disclosing their holdings in Madrigal Pharmaceuticals, including common stock, convertible preferred stock, and prefunded warrants. The filing indicates continued significant ownership by the Baker Brothers funds.

Key details

Common stock held by 667, L.P.shares 195K
Common stock held by Baker Brothers Life Sciences, L.P.shares 2.0M
Total common stock heldshares 2.2M
Series A Convertible Preferred Stock held by 667, L.P.shares 200K
Series A Convertible Preferred Stock held by Baker Brothers Life Sciences, L.P.shares 1.8M
Total Series A Convertible Preferred Stock heldshares 2.0M
Series B Convertible Preferred Stock held by 667, L.P.shares 39K
Series B Convertible Preferred Stock held by Baker Brothers Life Sciences, L.P.shares 361K
Total Series B Convertible Preferred Stock heldshares 400K
Prefunded Warrants held by 667, L.P.warrants 212K
Prefunded Warrants held by Baker Brothers Life Sciences, L.P.warrants 2.5M
Total Prefunded Warrants heldwarrants 2.7M
Filer/shareholderBaker Brothers Life Sciences, L.P.
Filer/shareholder667, L.P.
IssuerMadrigal Pharmaceuticals, Inc.

✦ Ask GOAX AI about this filing — what it means for MDGL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MDGL?

Click here

Frequently asked questions

What did MDGL file with the SEC on Nov 6, 2026?

MDGL filed a SCHEDULE 13D/A (Activist campaign). Baker Brothers Life Sciences, L.P. and affiliated funds filed an amended Schedule 13D disclosing their holdings in Madrigal Pharmaceuticals, including common stock, convertible preferred stock, and prefunded warrants. The filing indicates continued significant ownership by the Baker Brothers funds.

What does a activist campaign mean for MDGL stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

Other MDGL SEC filings

Get alerts when MDGL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days